Teva Pharmaceuticals

Teva Pharmaceuticals
Last activity: 29.06.2016
Categories: WebsiteSpecialtySocialProductPageMedTechInformationDrugCorporateContent
This Facebook page will be used for sharing company news and information about Teva Pharmaceuticals globally, managed by the Corporate Communications team on Teva’s behalf. This Facebook page is primarily for discussing news, events, featured business activities as well as topics related to health and wellness. We are excited to interact with you on our social channels, and look forward to fruitful and engaging dialogue. This is not a forum to discuss treatments or conditions, or as a venue for reporting adverse events or side effects. If you have a specific question about our products or services, please visit the Contact Us section of our corporate website: If you are reporting an adverse event or side effect relating to one of our products, please contact or submit your information through the Contact Us section of our corporate website at If you are having a life-threatening emergency, please contact your physician or seek local emergency assistance. We welcome your interactions, and we’ll try to reply to questions in a timely manner. Due to the limitations of these social channels and the regulated nature of the pharmaceutical industry, our replies may be brief. When possible, we will try to direct you to additional relevant information or support. Teva’s corporate social accounts will be regularly monitored and updated during business hours, Monday to Friday. Comments or questions posted outside of this time will be responded to as soon as possible during business hours. Social channels may occasionally be unavailable and we accept no responsibility for lack of service due to the channel platform’s downtime. When interacting with Teva on social channels, we encourage you to be respectful and polite; and to avoid sharing fraudulent, personally identifying, or confidential content. We will not respond to foul language; disparaging, defamatory, or inflammatory comments; or topics unrelated to Teva, and we reserve the right to delete inappropriate comments from our page as necessary. Disclaimers: We cannot share specific information about our products; for product-related information, please visit the relevant country or product website or submit your question through our website: We cannot comment on or respond to issues related to legal and financial matters, regulatory issues, or proprietary information on social channels. Our social accounts may provide links to independent third-party sites in posts and tweets. Teva has no way of controlling the content of the content of third-party sites, nor does Teva endorse, or is Teva responsible for, the content on third-party sites. Teva does not endorse, and is not responsible for, the content of any social accounts that the Teva social accounts follow.
Location: Israel, Tel Aviv District, Tel Aviv-Yafo
Employees: 10001+
Total raised: $35M
Founded date: 1901

Investors 2

Funding Rounds 1

08.01.2014Series E$35M-

Mentions in press and media 8

29.06.2016The biotech IPO feast flags as in­vestors lose their ap­peti...There was a time af­ter the 2008 crash that biotech IPOs were about as pop­u­lar as snow in March.
09.01.2014Auspex Pharmaceuticals Raises $20M in Series E LA JOLLA, CA, Auspex Pharmaceuticals, Inc., a Phase 3 clinical stage biopharmaceutical company ann...vcnewsdail...
08.01.2014Auspex Raises $35M, Makes New Board AppointmentAuspex Pharmaceuticals Inc. has raised $35 million through separate funding rounds — a $20 million
08.01.2014Auspex Pharmaceuticals Raises $35MAuspex Pharmaceuticals, Inc., a La Jolla, CA-based clinical stage biopharmaceutical company focused
12.03.2013Auspex Pharmaceuticals Receives Loan from Square 1 BankAuspex Pharmaceuticals, a San Diego-based clinical stage biotechnology company, received a a term
11.03.2013 Auspex Pharmaceuticals Gets Debt Funding San Diego-based biopharmaceuticals firm Auspex Pharmaceuticals has scored a new credit facility, fro...socaltech....
08.11.2012Auspex Pharmaceuticals Closes $25M Series D LA JOLLA, CA, Auspex Pharmaceuticals today announced that it has raised $25 million in a Series D ...vcnewsdail...
08.11.2012 Auspex Pharmaceuticals Raises $25M For Phase 3 Trials ...San Diego-based Auspex Pharmaceuticals announced this morning that it has raised $25M in a funding r...socaltech....

Reviews 0

Sign up to leave a review

Sign up Log In